Pacira BioSciences (PCRX)
(Delayed Data from NSDQ)
$26.33 USD
+0.83 (3.25%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $26.36 +0.03 (0.11%) 7:58 PM ET
5-Strong Sell of 5 5
A Value B Growth B Momentum A VGM
Earnings News For PCRX
-
Pacira (PCRX) Q4 Earnings Match, Exparel Sales Drive Revenues
-
Pacira: Q4 Earnings Snapshot
-
Pacira (PCRX) Matches Q4 Earnings Estimates
-
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
-
Pacira (PCRX) Earnings Expected to Grow: What to Know Ahead of Q4 Release
-
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues
-
Pacira (PCRX) Q3 Earnings and Revenues Miss, '23 View Updated
-
Pacira (PCRX) Misses Q3 Earnings and Revenue Estimates
-
Pacira: Q3 Earnings Snapshot
-
Pacira BioSciences Reports Third Quarter 2023 Financial Results
-
Pacira (PCRX) to Report Q3 Results: Wall Street Expects Earnings Growth
-
Pacira (PCRX) Down 8.9% Since Last Earnings Report: Can It Rebound?
-
Pacira (PCRX) Q2 Earnings and Sales Miss, '23 View Updated
-
Pacira (PCRX) Lags Q2 Earnings and Revenue Estimates
-
Pacira: Q2 Earnings Snapshot
-
Pacira BioSciences Reports Second Quarter 2023 Financial Results
-
Pacira (PCRX) to Report Q2 Results: Wall Street Expects Earnings Growth
-
Why Is Pacira (PCRX) Down 11.8% Since Last Earnings Report?
-
Pacira (PCRX) Q1 Earnings Miss Estimates, Revenues Beat
-
Pacira (PCRX) Lags Q1 Earnings Estimates
-
Pacira: Q1 Earnings Snapshot
-
Pacira BioSciences Reports First Quarter 2023 Financial Results
-
Earnings Preview: Pacira (PCRX) Q1 Earnings Expected to Decline
-
Why Is Pacira (PCRX) Down 6% Since Last Earnings Report?
-
Pacira's (PCRX) Q4 Earnings Match Estimates, Revenues Fall